< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 7.32

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance.

Authors: Cerulli Irelli E, Barone FA, Mari L, Morano A, Orlando B, Salamone EM, Marchi A, Fanella M, Fattouch J, Placidi F, Giallonardo AT, Izzi F, Di Bonaventura C

Date: 2022

Scope of interest: Epilepsy


Read details
Magazine 5.35

Management of Comorbidities in Older Persons With Type 2 Diabetes.

Authors: Morley JE, Abbatecola AM, Woo J.

Date: 2017

Scope of interest: ageing, geriatrics


Read details
Report/Poster of Convention/Congress Act

Experience of Frosinone Simt in the management of patients treated with Daratumumab

Authors: D’Amico C. et al.

Date: 2019

Scope of interest: Transfusion Medicine


Read details